Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Mainz Biomed NV - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
MYNZ
Nasdaq
8071
https://www.mainzbiomed.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Mainz Biomed NV
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
- Apr 10th, 2024 4:47 pm
Mainz Biomed Reports Full Year 2023 Financial Results
- Apr 9th, 2024 12:01 pm
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
- Mar 19th, 2024 12:01 pm
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
- Mar 18th, 2024 12:01 pm
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
- Mar 12th, 2024 12:01 pm
What Makes Mainz Biomed NV (MYNZ) a New Buy Stock
- Mar 8th, 2024 5:00 pm
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
- Mar 5th, 2024 1:01 pm
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
- Feb 28th, 2024 5:54 pm
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
- Feb 27th, 2024 1:01 pm
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
- Feb 22nd, 2024 7:21 pm
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
- Feb 22nd, 2024 1:01 pm
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
- Feb 21st, 2024 1:01 pm
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
- Feb 7th, 2024 5:13 pm
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
- Feb 6th, 2024 1:01 pm
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
- Feb 1st, 2024 9:17 pm
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
- Jan 11th, 2024 1:01 pm
2024 Marks a New Era Of Pharmaceutical Innovation
- Jan 9th, 2024 8:40 pm
Mainz Biomed Provides Year-End Corporate Review 2023
- Jan 9th, 2024 1:01 pm
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
- Dec 29th, 2023 7:48 pm
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
- Dec 19th, 2023 1:01 pm
Scroll